State
73,817 recalls have nationwide distribution and so reach New York. 12,956 additional recalls listed New York specifically in their distribution scope.
Of the 12,956 recalls naming New York we have scored against our rubric, 1,508 (12%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3,702 (29%) are Severe.
Which agencies issued them
These figures cover only the 12,956 recalls whose distribution notice names New York specifically. The 73,817 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Pharmedium Services, LLC is recalling Dexamethasone Sodium Phosphate in all strengths and packaging due to a lack of sterility assurance.
Harley-Davidson is recalling specific detachable saddlebags because the latching arm may disengage, allowing the bag to separate from the motorcycle while riding.
Arrow International is recalling 5,926 Multi Lumen Central Venous Catheterization Kits because they may contain the incorrect Springwire Guide.
Forest River is recalling 2018 Glaval Bus Commute vehicles because hazard lights may not function when the ignition is off, increasing crash risk.
Arrow International Inc is recalling specific lots of AGB+ Multi Lumen Central Venous Catheterization Kits because they may contain the incorrect Springwire Guide.
Lemur Group is recalling PL Sleep children's nightgowns because they fail to meet federal flammability standards, posing a risk of burn injuries.
DeRoyal Industries Inc is recalling 181 custom sterile surgical packs distributed in New York due to a Terumo valve defect causing no flow.
Flexfrost is recalling 1200/4 oz cups of Chocolate Protein Ice Cream due to insufficient pasteurization monitoring measures identified by the Ohio Department of Agriculture.
Flexfrost is recalling 3120 4-ounce cups of Protein Ice Cream Coffee because the Ohio Department of Agriculture found insufficient pasteurization monitoring measures.
Boston Scientific is recalling 22,916 units of the Innova Self-Expanding Stent System because the stent may not fully release from the delivery system.
Boston Scientific is recalling 22,916 Innova Self-Expanding Stent Systems because they may not fully release from the delivery system.
Roche Diagnostics is recalling 399 Cobas 8000 Modular Series systems due to a software failure that may reset settings to defaults, creating a risk of incorrect test results.
Arrow International is recalling 601 PICC powered by VPS Stylet kits because they may contain an incorrect catheter length.
Pentax of America Inc is recalling 559 Video Duodenoscopes to replace specific components and update inspection protocols to mitigate the potential risk of infection.
Cosman Medical is recalling Nitinol TC Reusable Electrodes because epoxy damage after reprocessing can prevent the removal of blood and tissue residuals.
Arrow International is recalling 5,926 Central Venous Catheterization Kits with Blue FlexTip Catheters because they may contain the incorrect Springwire Guide.
American Pharmaceutical Ingredients LLC is recalling Testosterone USP (Micronized) (Yam) for prescription compounding due to CGMP deviations regarding stability data and expiration date controls.
American Pharmaceutical Ingredients is recalling Levofloxacin Hemihydrate USP for prescription compounding due to missing stability data supporting expiration dates.
American Pharmaceutical Ingredients LLC is recalling Biotin USP for prescription compounding due to CGMP deviations, specifically a lack of stability data and controls to support expiration dates.
Arrow International Inc. is recalling 5,926 ARROWg+ard Blue Plus Multi Lumen CVC kits that may contain the incorrect Springwire Guide.
American Pharmaceutical Ingredients is recalling specific lots of Tacrolimus USP for prescription compounding because the manufacturer lacked stability data to support the assigned expiration dates.
American Pharmaceutical Ingredients LLC is recalling Gabapentin USP for prescription compounding due to a lack of stability data and controls to support assigned expiration dates.
American Pharmaceutical Ingredients is recalling Amitriptyline HCl USP for prescription compounding due to a lack of stability data supporting the assigned expiration dates.
American Pharmaceutical Ingredients LLC is recalling Naltrexone HCl USP for prescription compounding because the manufacturer lacked stability data to support the assigned expiration dates.
American Pharmaceutical Ingredients LLC is recalling Estrone USP for prescription compounding because it lacks stability data and controls to support its expiration dates.